Diffusion- and T2-weighted imaging: evaluation of oedema reduction in focal cerebral ischaemia by the calcium and serotonin antagonist levemopamil.

Magnetic resonance imaging (MRI) was used to evaluate beneficial drug effects in a rat model of focal cerebral ischaemia. Extent of cerebral oedema was measured on T2-weighted images 24 hr after permanent middle cerebral artery occlusion (MCAO) in spontaneously hypertensive rats. Areas of increased signal intensity strongly correlate with histochemically determined areas of ischaemia in corresponding brain planes (r = 0.84; p < .001). In a separate cohort of animals, spatial progression of oedema formation was studied at 3, 24, 48, and 72 hr after MCAO showing a maximum extent at 48 hr. Early events in cerebral ischaemia were monitored using diffusion-weighted imaging. Effects of levemopamil [formerly (S)-emopamil], a calcium and serotonin antagonist, and the reference compound isradipine were quantified on high resolution T2-weighted spin-echo images 24 hr after MCAO. Combined pre- and posttreatment with isradipine showed a 21% inhibition of oedema progression. Application of a single dose (10 mg/kg) of levemopamil either 30 min before or 2 hr after MCAO revealed a diminution of oedematous areas by 19% and 25%, respectively. Levemopamil reduces the extent of ischaemic brain oedema in an established stroke model.

[1]  D. Graham,et al.  Focal Cerebral Ischaemia in the Rat: 1. Description of Technique and Early Neuropathological Consequences following Middle Cerebral Artery Occlusion , 1981, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  R. Spetzler,et al.  Magnetic resonance imaging: comparative study of radiofrequency pulse techniques in the evaluation of focal cerebral ischemia. , 1985, Neurosurgery.

[3]  H. Hofmann,et al.  (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 3rd communication: effect on postischemic cerebral blood flow and metabolism, and ischemic neuronal cell death. , 1989, Arzneimittel-Forschung.

[4]  K. Hossmann,et al.  Relationship between cerebral blood flow and blood-brain barrier permeability of sodium and albumin in cerebral infarcts of rats. , 1990, Acta neurochirurgica. Supplementum.

[5]  A. Betz,et al.  Extravasation of albumin in ischaemic brain oedema. , 1990, Acta Neurochirurgica Supplementum.

[6]  M Brant-Zawadzki,et al.  MR imaging of acute experimental ischemia in cats. , 1986, AJNR. American journal of neuroradiology.

[7]  J. Kurhanewicz,et al.  Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. , 1990, AJNR. American journal of neuroradiology.

[8]  T J Brady,et al.  True three-dimensional nuclear magnetic resonance neuro-imaging in ischemic stroke: correlation of NMR, X-ray CT and pathology. , 1983, Stroke.

[9]  M. Raschack,et al.  (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 1st communication: pharmacological profile. , 1989, Arzneimittel-Forschung.

[10]  R. Russell,et al.  Cerebral edema following carotid artery ligation in the gerbil. , 1973, Archives of neurology.

[11]  S. Matsui,et al.  Correlations between Proton Nuclear Magnetic Resonance Imaging and Retrospective Histochemical Images in Experimental Cerebral Infarction , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  M. Rudin,et al.  Reduction of neural damage in irreversible cerebral ischemia by calcium antagonists. , 1988, Neurochemical pathology.

[13]  W S Hinshaw,et al.  Cranial anatomy and detection of ischemic stroke in the cat by nuclear magnetic resonance imaging. , 1982, Radiology.

[14]  R. Schmidt,et al.  Nuclear magnetic resonance image white matter lesions and risk factors for stroke in normal individuals. , 1988, Stroke.

[15]  J. Kucharczyk,et al.  Early detection of regional cerebral ischemia in cats: Comparison of diffusion‐ and T2‐weighted MRI and spectroscopy , 1990, Magnetic resonance in medicine.

[16]  B. Lin,et al.  (S)-emopamil protects against global ischemic brain injury in rats. , 1990, Stroke.

[17]  S. Jones,et al.  Evolving focal cerebral ischemia in cats: spatial correlation of nuclear magnetic resonance imaging, cerebral blood flow, tetrazolium staining, and histopathology. , 1988, Stroke.

[18]  R. Lenkinski,et al.  Quantitative comparison of magnetic resonance imaging (MRI) and histologic analyses of focal ischemic damage in the rat , 1991, Brain Research Bulletin.

[19]  D. Le Bihan,et al.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. , 1988, Radiology.

[20]  F. Block,et al.  S-emopamil ameliorates ischemic brain damage in rats: histological and behavioural approaches. , 1990, Life sciences.

[21]  M. Ginsberg,et al.  (S)‐Emopamil, a novel calcium channel blocker and serotonin S2 antagonist, markedly reduces infarct size following middle cerebral artery occlusion in the rat , 1988, Neurology.

[22]  M. Rudin,et al.  Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imaging. , 1986, Stroke.

[23]  S. Ohnishi,et al.  Interrelationship of brain edema, motor deficits, and memory impairment in rats exposed to focal ischemia. , 1989, Stroke.

[24]  L. Pitts,et al.  Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. , 1986, Stroke.

[25]  F. Buonanno,et al.  NMR-neuropathologic correlation in stroke. , 1987, Stroke.

[26]  J. Kucharczyk,et al.  Nicardipine reduces ischemic brain injury. Magnetic resonance imaging/spectroscopy study in cats. , 1989, Stroke.

[27]  W. Pulsinelli,et al.  Focal Brain Ischemia in the Rat: Methods for Reproducible Neocortical Infarction Using Tandem Occlusion of the Distal Middle Cerebral and Ipsilateral Common Carotid Arteries , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  S. Naruse,et al.  Effects of atrial natriuretic peptide on ischemic brain edema in rats evaluated by proton magnetic resonance method. , 1991, Stroke.

[29]  M. Limburg,et al.  Timing of Hospital Admission in a Prospective Series of Stroke Patients , 1991 .

[30]  M. Rudin,et al.  Cerebrovascular, biochemical, and cytoprotective effects of isradipine in laboratory animals. , 1989, The American journal of medicine.

[31]  C. Castleden,et al.  Factors Delaying Hospital Admission After Stroke in Leicestershire , 1992, Stroke.

[32]  W. Steinbrich,et al.  [MR of ischemic brain diseases. A comparison with CT, PET (18-fluorodeoxyglucose) and angiographic results]. , 1986, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[33]  J. Schenck,et al.  An efficient, highly homogeneous radiofrequency coil for whole-body NMR imaging at 1.5 T , 1985 .

[34]  R. Busto,et al.  Postischemic (S)-emopamil therapy ameliorates focal ischemic brain injury in rats. , 1991, Stroke.

[35]  P. Grenier,et al.  MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. , 1986, Radiology.

[36]  C. Dunnett.  A Multiple Comparison Procedure for Comparing Several Treatments with a Control , 1955 .